[Procalcitonin, a useful biomarker in pediatric urinary tract infection]

Area of Science:

• Pediatric Nephrology
• Infectious Diseases
• Biomarker Research

Background:

• Urinary tract infections (UTIs) are common bacterial infections in febrile children.
• Accurate diagnosis of acute pyelonephritis (APN) and vesico-ureteral reflux (VUR) is crucial to prevent renal scarring and long-term complications.
• Current gold standard tests (DMSA scan, cystography) have limitations like pain, cost, and feasibility.

Purpose of the Study:

• To evaluate procalcitonin as a reliable marker for diagnosing APN and VUR in children with UTIs.
• To explore procalcitonin's potential role in predicting renal parenchymal involvement and high-grade VUR.
• To assess procalcitonin's utility in guiding diagnostic decisions for pediatric UTIs.

Main Methods:

• Review of existing studies on procalcitonin's efficacy in pediatric UTIs.
• Analysis of procalcitonin's correlation with APN, renal scarring, and VUR.
• Comparison of procalcitonin with traditional diagnostic methods.

Main Results:

• Procalcitonin is a reliable marker for bacterial infections.
• Procalcitonin demonstrated predictive value for renal parenchymal involvement in APN and late renal scars.
• Procalcitonin also showed potential in predicting high-grade VUR.

Conclusions:

• Procalcitonin may serve as a valuable, less invasive tool in the diagnostic workup of pediatric UTIs.
• Further validation and impact studies are needed before widespread clinical implementation.
• Procalcitonin could help navigate the complex decision-making process for selecting appropriate examinations after UTI in children.